Skip to main content
. 2019 Jan 17;14(1):e0210796. doi: 10.1371/journal.pone.0210796

Fig 2. Impact of anti-CD200R antibodies (clone OX131) on the growth of EMT6 tumors.

Fig 2

(A) EMT6 tumor growth measured as a tumor volume. (B) Percentage of intratumoral myeloid cells (in immune gate CD45+). (C) Percentage of intratumoral myeloid cells—subpopulations in CD11b+ cells. (D) Percentage of intratumoral CD8+ T lymphocytes. Expression of IFN-γ and TNF-α in the intratumoral CD8+ T lymphocytes (E) (F) respectively. Mice were treated with control or anti-CD200R (clone OX131). N = 7–10 / group, data are presented as mean ± SEM. *P < 0.05.